Business · 23/10/1998Updated: 10/17/2026 · 1 min read
FDA Issues Final Rule for Professional Labeling of Aspirin Products
Summary
The Food and Drug Administration (FDA) has finalized the professional labeling for over-the-counter aspirin products, including buffered aspirin and aspirin combined with antacids, to reflect the latest information on cardiovascular, cerebrovascular, and rheumatologic uses.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →